Better Health,
Brighter Future
Newsroom
Careers
Investors
Patients
HCPs
Worldwide
Who We Are
About Takeda
How can we do more for our patients?
Everything at Takeda starts with this question.
Learn more
Our People
Corporate Philosophy
Company Information
Company Facts
History
Worldwide Offices
Executive Leadership
Positions
Contact Us
From the CEO
How We Work
Life at Takeda
Design Concept
Where we work
Corporate Governance
Risk & Crisis Management
Global Ethics & Compliance
Celebrating the grand opening of Takeda Global Headquarters
LEARN MORE
What We Do
Our Business
We will become a global, values-based, R&D-driven, biopharmaceutical leader
Learn more
Research & Development
Ecosystem for Health Innovation
Our Pipeline
Takeda Clinical Trial Transparency
Investigator Initiated Sponsored Research
Therapeutic Areas
Our Products
Alliances & Partnerships
Access to Medicines
Suppliers
Sustainable Procurement
Supplier Code of Conduct
Supplier Diversity
Pharmaceutical Supply Chain Initiative
Supplier Qualification & Due Diligence
T-CiRA
We focus on our core therapeutic areas.
LEARN MORE
Our Stories
Our Stories
A selection of stories related to Innovation, Caring and Heritage
Learn more
Innovation
Quality at Takeda
The Key Elements at the Heart of Our Innovation
Caring
Medicine for the World
Safeguarding Plant Diversity
Takeda at TICAD
Going Beyond Medicines
Change the World
Healthcare for All
Shared Knowledge for a Better Life for All
Heritage
Keys to Aging Gracefully
Shared Knowledge for a Better Life for All
LEARN MORE
Corporate Responsibility
Takeda's CSR
Takeda is committed to creating corporate value by developing outstanding pharmaceutical products and conducting corporate citizenship activities.
LEARN MORE
Our CSR Philosophy
Human Rights
Labor
Environment
Anti-Corruption
Activities
Global CSR Program
SDGs
Takeda Initiative
IDEEL Program
HERhealth
Global Relay for Life
Digital Birth Registration
Corporate Citizenship Videos
Sustainable Value Report
How We Drive: Sustainable Value
Takeda is committed to contributing to the long-term health of people through disease prevention.
LEARN MORE
HOME
Newsroom
News Releases
Share:
Newsroom
News Releases
In the News
Featured Topics
Corporate Materials
Social Media
Message from the CEO
News Releases
Enter
All
Last 12 months
2017
2016
2015
2014
March 2019
March 26, 2019
3/26/2019
Takeda Presents New Data at the Endocrine Society’s 2019 Annual Meeting about the Patient Burden and Long-Term Impact of Chronic Hypoparathyroidism
March 9, 2019
3/9/2019
Vedolizumab Achieves Superior Rates of Clinical Remission vs. Adalimumab in First Ever Head-to-Head Biologic Clinical Study in Ulcerative Colitis
February 2019
February 20, 2019
2/20/2019
Takeda's Sustainability Activities Receive Multiple Accolades by Rigorous ESG Evaluators
February 15, 2019
2/15/2019
Shire's Full Year 2018 Results
February 15, 2019
2/15/2019
Notice Regarding Issue of Hybrid Bonds to replace Senior Short Term Loan (Offering of Subordinated Bonds)
February 11, 2019
2/11/2019
European Commission Approves ADCETRIS with AVD for Adults with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma
February 6, 2019
2/6/2019
Takeda announces results from first-of-its-kind phase IIIb/IV trial PROPEL – a randomized PK-guided prophylaxis study evaluating higher factor VIII levels in hemophilia A– at EAHAD 2019
February 4, 2019
2/4/2019
Takeda to Highlight Advancements in Rare Lysosomal Storage Disorders at Global Scientific Meeting
February 1, 2019
2/1/2019
Takeda Reports Third Quarter FY2018 Results
1
2
3
4
5
・For legacy Shire information, click here
TOP
